Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Editors Pick
    • ENDS White Paper: Why...

    ENDS White Paper: Why ICMR is calling for a ban on ENDS or e- cigarettes

    Written by Deepanjana Sarkar Published On 2019-06-02T20:20:17+05:30  |  Updated On 2 Jun 2019 8:20 PM IST
    ENDS White Paper: Why ICMR is calling for a ban on ENDS or e- cigarettes

    Delhi- The apex medical regulatory body of the country, Indian Council of Medical Research (ICMR), called for a complete ban on Electronic Nicotine Delivery System (ENDS) or e-cigarettes in a white paper released on May 31st ,2019 on the eve of World No Tobacco Day.The decision was taken based on the scientific evidence which is in stark contrast with the growing claims made by the e-cigarette manufacturers that it facilitate the cessation of smoking


    The white paper pointed out that smoke or ‘vape’ which is produced by the e-cigarette contains a varying concentration of nicotine which is considered as one of the most addictive substances and the rapidity at which it is introduced into the body, age of first exposure and the dosage administered all add to determine the potential risk of a person being addicted to it throughout life. These devices also contain other ingredients as flavoring agents and vaporizers, which are also found to be harmful to health.


    The white paper adds the use of e-cigarettes not only poses a potential risk for the user causing adverse effects which include DNA damage; carcinogenesis; cellular, molecular and immunological toxicity; respiratory, cardiovascular and neurological disorders to its users but passive smoking can adversely affect on foetal development and pregnancy. Also, it stated that there are reports of poisoning due to accidental swallowing by children. These devices also can cause fire and explosion.


    The ban is supported by the union health ministry after the release of the findings of a survey.


    Studies have found that the percentage of students who initiate the use of e-cigarettes and hookah smoking before 10 years of age has increased from 26 percent to 45 percent in the last 15 years, reports PTI.


    Based on the currently available scientific data from multiple streams of research, the ICMR recommends a complete prohibition on ENDS or e-cigarettes in India in the greater interest of protecting public health, in accordance with the precautionary principle preventing public harm from a noxious agent, considering the following facts and circumstances


    Following are the key recommendations made by the ICMR based on evidence supporting a ban on e-cigarettes.

    • ENDS or e-cigarettes contain nicotine solution, which is highly addictive and also contain other ingredients as flavoring agents and vaporizers, which are also harmful to health.

    • Use of ENDS or e-cigarettes has documented adverse effects on humans which include DNA damage; carcinogenesis; cellular, molecular and immunological toxicity; respiratory, cardiovascular and neurological disorders and adverse impact on foetal development and pregnancy.

    • The magnitude of potential short-term and long-term health risks to the users still remains undetermined at the population level since the products are recent and come in diverse forms.

    • Whereas, the degree to which, if at all, the ENDS or e-cigarettes benefit as tobacco cessation aides is not firmly established, evidence suggests that there is a risk of dual-use to some extent and initiation to tobacco addiction to non-smokers. Hence, on balance, these products have a net negative impact on public health.

    • Use of ENDS can open a gateway for new tobacco addiction which is a potential threat to the country’s tobacco control laws and on-going tobacco control programs.

    • The rapidly increasing trend of use of ENDS or e-cigarettes by young persons, in countries where it was introduced, underscores a potential threat to public health.


    Prof. Balram Bhargava, Secretary, Department of Health Research, Government of India and Director General ICMR, New Delhi said, “Given the extent of harmful health effects of e-cigarettes to the users as well passive exposure and multiple faces of the ENDS or e-cigarettes use epidemic around the world” where it was introduced, if no appropriate interventions are taken at the right time by bringing together all stakeholders under one umbrella to prevent these impending epidemics of e-cigarettes use, it can lead to a public health disaster in India.


    Attached is the White paper below
    carcinogenesiscardiovascular disordersDNA damagee-cigarette bane-cigarettesElectronic Nicotine Delivery Systemflavoring agentHookahhookah smokingICMRIndian Council of Medical ResearchNicotinepoisoningPregnancyProf. Balram BhargavaProf. K. Srinath Reddyrespiratory disorderssmokingtoxicityvaporizersWhite Paper

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Deepanjana Sarkar
    Deepanjana Sarkar
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok